Extravasation of Blood and Blood Toxicity Drives Tubular Injury from RBC Trapping in Ischemic AKI

Abstract

Red blood cell (RBC) trapping is common in ischemic acute kidney injury (AKI) and presents as densely packed RBCs that accumulate within and engorge the kidney medullary circulation. In this study, we tested the hypothesis that “RBC trapping directly promotes tubular injury independent of extending ischemia time.” Studies were performed on rats. Red blood cell congestion and tubular injury were compared between renal arterial clamping, venous clamping, and venous clamping of blood-free kidneys. Vessels were occluded for either 15 or 45 min with and without reperfusion. We found that RBC trapping in the medullary capillaries occurred rapidly following reperfusion from renal arterial clamping and that this was associated with extravasation of blood from congested vessels, uptake of blood proteins by the tubules, and marked tubular injury. To determine if this injury was due to blood toxicity or an extension of ischemia time, we compared renal venous and arterial clamping without reperfusion. Venous clamping resulted in RBC trapping and marked tubular injury within 45 min of ischemia. Conversely, despite the same ischemia time, RBC trapping and tubular injury were minimal following arterial clamping without reperfusion. Confirming the role of blood toward tubular injury, injury was markedly reduced in blood-free kidneys with venous clamping. Our data demonstrate that RBC trapping results in the rapid extravasation and uptake of blood components by tubular cells, causing toxic tubular injury. Tubular toxicity from extravasation of blood following RBC trapping appears to be a major component of tubular injury in ischemic AKI, which has not previously been recognized.

Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges

“…For example, during ischaemia/reperfusion (I/R)-induced AKI, there is hypoxic and metabolic/mitochondrial injury, plus additional necrosis and apoptosis of TECs due to trapping of erythrocytes and subsequent toxicity. 54 Major mechanisms of EV action relevant to AKI therapy include acute protection of parenchymal cells by reducing apoptosis, stimulation of cell proliferation, modulation of inflammation and immune cell recruitment, promotion of endothelial cell angiogenesis, and modulation of matrix remodeling and fibrosis by fibroblasts. 55 EV cargo constituents are discussed in detail in Section 3, and studies describing their therapeutic activities are discussed in Section 5.…”

Rethinking Ischemic Acute Kidney Injury as Nephrotoxicity

“…However, the work from McLarnon and colleagues in the recent issue of Function provides an important example of why the complexities of AKI cannot be fully understood without considering the basic anatomy of physiology of the kidney, especially the role of renal hemodynamics. 1 …”